Similar articles for PMID: 25175271

Year	Number of Results
1921	1
1950	1
1951	1
1952	1
1957	1
1959	2
1960	1
1961	1
1971	1
1988	1
1989	1
1990	4
1991	2
1992	2
1994	3
1995	3
1997	2
1998	2
1999	5
2000	1
2001	7
2002	2
2003	5
2004	5
2005	12
2006	5
2007	9
2008	4
2009	11
2010	20
2011	17
2012	10
2013	14
2014	19
2015	19
2016	21
2017	14
2018	11
2019	19
2020	28
2021	30
2022	21
2023	8
2024	1

1

The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.

Kaya B, Apaydin N, Loukas M, Tubbs RS. Kaya B, et al. J Plast Reconstr Aesthet Surg. 2014 Dec;67(12):1663-8. doi: 10.1016/j.bjps.2014.07.043. Epub 2014 Aug 7. J Plast Reconstr Aesthet Surg. 2014. PMID: 25175271

2

Intramuscular nerve distribution of the masseter muscle as a basis for botulinum toxin injection.

Kim DH, Hong HS, Won SY, Kim HJ, Hu KS, Choi JH, Kim HJ. Kim DH, et al. J Craniofac Surg. 2010 Mar;21(2):588-91. doi: 10.1097/SCS.0b013e3181d08bb3. J Craniofac Surg. 2010. PMID: 20489458

3

Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.

Kim HJ, Yum KW, Lee SS, Heo MS, Seo K. Kim HJ, et al. Dermatol Surg. 2003 May;29(5):484-9. doi: 10.1046/j.1524-4725.2003.29117.x. Dermatol Surg. 2003. PMID: 12752515 Clinical Trial.

4

Topography of the masseter muscle in relation to treatment with botulinum toxin type A.

Hu KS, Kim ST, Hur MS, Park JH, Song WC, Koh KS, Kim HJ. Hu KS, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Aug;110(2):167-71. doi: 10.1016/j.tripleo.2009.12.036. Epub 2010 Apr 9. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010. PMID: 20382049

5

Ultrasonographic Considerations for Safe and Efficient Botulinum Neurotoxin Injection in Masseteric Hypertrophy.

Lee HJ, Jung SJ, Kim ST, Kim HJ. Lee HJ, et al. Toxins (Basel). 2021 Jan 4;13(1):28. doi: 10.3390/toxins13010028. Toxins (Basel). 2021. PMID: 33406757 Free PMC article.

6

Botulinum toxin type A treatment for contouring of the lower face.

Park MY, Ahn KY, Jung DS. Park MY, et al. Dermatol Surg. 2003 May;29(5):477-83; discussion 483. doi: 10.1046/j.1524-4725.2003.29116.x. Dermatol Surg. 2003. PMID: 12752514

7

Course of the masseteric nerve in masseter muscle.

Hwang K, Kim YJ, Chung IH, Song YB. Hwang K, et al. J Craniofac Surg. 2005 Mar;16(2):197-200. doi: 10.1097/00001665-200503000-00003. J Craniofac Surg. 2005. PMID: 15750414

8

Effects of botulinum toxin type A on contouring of the lower face.

Choe SW, Cho WI, Lee CK, Seo SJ. Choe SW, et al. Dermatol Surg. 2005 May;31(5):502-7; discussion 507-8. doi: 10.1111/j.1524-4725.2005.31151. Dermatol Surg. 2005. PMID: 15962731 Clinical Trial.

9

Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.

Gaofeng L, Jun T, Bo P, Bosheng Z, Qian Z, Dongping L. Gaofeng L, et al. J Plast Reconstr Aesthet Surg. 2010 Dec;63(12):2026-31. doi: 10.1016/j.bjps.2009.12.019. Epub 2010 Jan 29. J Plast Reconstr Aesthet Surg. 2010. PMID: 20116356

10

The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.

Ahn KY, Kim ST. Ahn KY, et al. Plast Reconstr Surg. 2007 Nov;120(6):1662-1666. doi: 10.1097/01.prs.0000282309.94147.22. Plast Reconstr Surg. 2007. PMID: 18040203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

299 results

Results by year